Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$90,548
New position
Shares Held
766
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 62.01044386422977.ToString("F0")%
Shared 0.ToString("F0")%
None 37.989556135770236.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Silver Grove Financial Group, Inc. holds $93,567 across 3 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (96.8% of the industry book) .
All Filings in ZTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $90,548 | 766 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||